DekaBank Deutsche Girozentrale
ACOR

DekaBank Deutsche Girozentrale’s Acorda Therapeutics ACOR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-152
Closed -$55K – 1241
2019
Q3 		$55K Sell
152
-151
-50% -$82.1K ﹤0.01% 940
2019
Q2 		$269K Buy
303
+89
+42% +$109K ﹤0.01% 985
2019
Q1 		$735K Buy
214
+27
+14% +$48.6K ﹤0.01% 841
2018
Q4 		$332K Sell
187
-27
-13% -$58.8K ﹤0.01% 898
2018
Q3 		$735K Buy
214
+9
+4% +$27.9K ﹤0.01% 859
2018
Q2 		$679K Buy
205
+14
+7% +$42.9K ﹤0.01% 844
2018
Q1 		$544K Sell
191
-4
-2% -$12K ﹤0.01% 855
2017
Q4 		$504K Hold
195
– – ﹤0.01% 819
2017
Q3 		$504K Hold
195
– – ﹤0.01% 825
2017
Q2 		$457K Hold
195
– – ﹤0.01% 849
2017
Q1 		$626K Sell
195
-17
-8% -$48.9K 0.01% 701
2016
Q4 		$461K Buy
212
+16
+8% +$38K ﹤0.01% 672
2016
Q3 		$485K Hold
196
– – 0.01% 673
2016
Q2 		$597K Sell
196
-5
-2% -$16.3K 0.01% 649
2016
Q1 		$636K Buy
201
+19
+10% +$78.9K 0.01% 612
2015
Q4 		$938K Buy
182
+3
+2% +$13.1K 0.01% 572
2015
Q3 		$570K Buy
179
+6
+3% +$23.3K 0.01% 663
2015
Q2 		$690K Buy
173
+6
+4% +$23.2K 0.01% 632
2015
Q1 		$666K Sell
167
-20
-11% -$91.6K 0.01% 650
2014
Q4 		$910K Sell
187
-16
-8% -$68.7K 0.01% 576
2014
Q3 		$827K Buy
203
+4
+2% +$15K 0.01% 545
2014
Q2 		$806K Sell
199
-10
-5% -$40.8K 0.01% 532
2014
Q1 		$952K Buy
209
+16
+8% +$64.7K 0.02% 479
2013
Q4 		$670K Buy
193
+4
+2% +$15.6K 0.01% 507
2013
Q3 		$776K Buy
+189
New +$814K 0.01% 477

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ACOR Position: Q4 2019 in Review

DekaBank Deutsche Girozentrale sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 152 shares — an estimated $55K sold.

DekaBank Deutsche Girozentrale first reported a position in ACOR in Q3 2013 and held it in 25 quarters. The position peaked at $952K in Q1 2014. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 152 Acorda Therapeutics shares in Q4 2019, an estimated $55K.
  • DekaBank Deutsche Girozentrale first reported a position in Acorda Therapeutics in Q3 2013 and held it in 25 quarters.
  • DekaBank Deutsche Girozentrale's Acorda Therapeutics position peaked at $952K in Q1 2014.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2019, filed 4 Feb 2020.